AstraZeneca has made cutbacks in R&D this year while boosting efforts tap universities and other outside groups for cutting edge science. For instance, the company's Neuroscience Innovative Medicines ...

Global biopharmaceutical company, AstraZeneca, has launched a new science blog, LabTalk, which provides scientists with an online forum to discuss cutting-edge science and innovative ideas and ...

Erdem Gültekin Tamgüney discusses the future of neurodegeneration research and his work exploring the link between stroke and Parkinson’s disease. The brain’s intractable nature makes ...